Showing 1 - 9 of 9 trials – Showing only trials currently accepting patients

• [18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers

  Stanford is currently accepting patients for this trial.

• A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors

  Stanford is currently accepting patients for this trial.

• Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

  Stanford is currently accepting patients for this trial.

• GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas(DIPG) & Spinal Diffuse Midline Glioma(DMG)

  Stanford is currently accepting patients for this trial.

• Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM

  Stanford is currently accepting patients for this trial.

• Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

  Stanford is currently accepting patients for this trial.

• A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration

  Stanford is currently accepting patients for this trial.

• A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

  Stanford is currently accepting patients for this trial.

• Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma

  Stanford is currently accepting patients for this trial.